<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>936</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>10586072</PubmedId>
            <Abstract>Mice infected with Listeria monocytogenes (LM) generate CD8 effectors specific for f-MIGWII, the amino terminus of the bacterial product lemA presented by the class Ib MHC molecule H2 M3wt. lemA has several distinctive properties: 1) it is readily presented as an exogenous Ag in the absence of bacterial infection; 2) it is processed by a TAP-independent pathway, which is sensitive to chloroquine, pepstatin, and brefeldin; and 3) the immunogenic portion of the molecule is extremely resistant to proteolytic degradation even by proteinase K. To assess the structural basis for these findings, we expressed a truncated variant (t-lemA) containing the amino-terminal hexapeptide and the subsequent 27 amino acids linked to a histidine tail in Escherichia coli, and purified the product by affinity chromatography. Purified t-lemA could be presented to f-MIGWII-specific effectors by macrophages and fibroblasts at 1-10 nM. Unlike f-MIGWII, which binds directly to H2 M3wt, t-lemA required processing by a chloroquine-, pepstatin-, and brefeldin-sensitive pathway. Brefeldin sensitivity often implies endogenous processing in the cytoplasm, but several lines of evidence suggest translocation to the cytoplasm and proteosomal degradation are not critical for t-lemA presentation. Unlike f-MIGWII, t-lemA was profoundly resistant to proteinase K, and, using 35S-labeled t-lemA, we could identify the region from position 1 to approximately 30 as the protease-resistant element. Thus, the hydrophobic peptide sequence following f-MIGWII can account for the unusual properties of lemA noted above. Analogous modification could be used to alter the properties of other peptide Ags presented by class I MHC products.</Abstract>
            <ArticleYear>1999</ArticleYear>
            <ArticlePages>6741-7</ArticlePages>
            <ArticleTitle>The adjacent flanking region plays a critical role in facilitating the presentation of the Listeria monocytogenes product lemA to H2 M3wt-restricted, peptide-specific murine CD8 cells.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Kurlander</LastName>
                    <ForeName>R J</ForeName>
                </Author>
                <Author>
                    <LastName>Chao</LastName>
                    <ForeName>E</ForeName>
                </Author>
                <Author>
                    <LastName>Fields</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Nataraj</LastName>
                    <ForeName>C</ForeName>
                </Author>
            </Authors>
            <Affiliations>Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA. rkurlander@nih.gov.</Affiliations>
            <ArticleChemicalList>ATP Binding Cassette Transporter, Subfamily B, Member 2;ATP-Binding Cassette Transporters;Bacterial Proteins;Epitopes, T-Lymphocyte;H-2 Antigens;H2-M3 antigen;Histocompatibility Antigens Class I;Peptide Fragments;TAP1 protein, human;Tap1 protein, mouse;Transcription Factors;lemA protein, bacterial;Endopeptidase K</ArticleChemicalList>
            <ArticleMeshHeadingsList>ATP Binding Cassette Transporter, Subfamily B, Member 2; ATP-Binding Cassette Transporters(immunology; metabolism); Amino Acid Sequence; Animals; Antigen Presentation(genetics); Bacterial Proteins(chemical synthesis; genetics; immunology; metabolism); Biological Transport(immunology); CD8-Positive T-Lymphocytes(immunology; metabolism); Cell Line; Cytoplasm(immunology; metabolism); Endopeptidase K(physiology); Epitopes, T-Lymphocyte(metabolism); Fibroblasts(immunology; metabolism); H-2 Antigens(genetics; immunology); Histocompatibility Antigens Class I(genetics; immunology); Listeria monocytogenes(genetics; immunology); Macrophages(immunology; metabolism); Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Mutagenesis, Insertional; Peptide Fragments(genetics; immunology; metabolism); Transcription Factors(chemical synthesis; genetics; immunology; metabolism)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>163</Volume>
                <Issue>12</Issue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <Issn>0022-1767</Issn>
                <MedlineTa>J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>f-MIGWII</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MIGWII</LinearSequence>
                        <ModifiedResidues>M1</ModifiedResidues>
                        <Modifications>Formylation|FORM</Modifications>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>6</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q8Y8E2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>393133</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Page 6742</LocationOfData>
                <EpitopeId>41710</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>6</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>N terminal hexamer of source protein, formylated, H2-M3 (non-classical Ib) MHC restricted.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>11395</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MIGWII</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>6</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>Q8Y8E2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>393133</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>f-MIGWII</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>393133</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Epitope specific CTL line CN.8 was maintained by weekly restimulation with heat killed source species and IL-2 in the presence of irradiated splenocytes.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>CN.8</AssayedTcrMoleculeName>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Bone Marrow</CellTissueType>
                            <CellType>Macrophage</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                            <SourceOrganismId>10000067</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>f-MIGWII</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MIGWII</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>6</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q8Y8E2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>393133</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>575</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Macrophages incubated with peptide are effectively lysed by epitope specific CTL. When infected with construct including the 27 following aa of source protein, a higher concentration is required to obtain the same amount of lysis. The presentation of the epitope without flanking regions is pepstatin, chloroquine and ammonium chloride insensitive, and only partially sensitive to brefeldin, implying this sequence conforms a minimal epitope without further processing necessary. The same results are obtained with fibroblasts as APCs. The treatment of epitope with Proteinase K abolishes its antigenicity, showing it can be degraded, while the longer construct is resistant to PK treatment.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

